Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Assets: 2024-2025

Historic Current Assets for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $620.7 million.

  • Kura Oncology's Current Assets rose 34.00% to $620.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $620.7 million, marking a year-over-year increase of 34.00%. This contributed to the annual value of $744.8 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Current Assets stood at $620.7 million for Q3 2025, which was down 5.97% from $660.1 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Current Assets ranged from a high of $744.8 million in Q4 2024 and a low of $463.2 million during Q3 2024.
  • Over the past 2 years, Kura Oncology's median Current Assets value was $620.7 million (recorded in 2025), while the average stood at $607.2 million.
  • Data for Kura Oncology's Current Assets shows a peak YoY surged of 34.65% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Current Assets stood at $744.8 million in 2024, then soared by 34.00% to $620.7 million in 2025.
  • Its last three reported values are $620.7 million in Q3 2025, $660.1 million for Q2 2025, and $724.2 million during Q1 2025.